1-3 of 3
Sandra Eketorp Sylvan, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Patients with Chronic Lymphocytic Leukemia (CLL) Receiving First Line Therapy: A Swedish Nation-Wide Study on 1053 Consecutive Patients Treated between 2007 and 2013

Sandra Eketorp Sylvan, MD PhD, Anna Asklid, MD, Hemming Johansson, Jenny Klintman, MD PhD, Jenny Bjellvi, MD, Staffan Tolvgård, MD, Eva Kimby, Stefan Norin, MD PhD, P-O Andersson, MD PhD Prof., Claes Karlsson, MD PhD, Karin Karlsson, MD, Birgitta Lauri, MD, Mattias Mattsson, MD, Anna Bergendahl Sandstedt, MD, Maria Strandberg, MD, Anders Österborg, MD PhD Prof., Lotta Hansson
Journal: Blood
Blood (2017) 130 (Supplement 1): 1744.
https://doi.org/10.1182/blood.V130.Suppl_1.1744.1744
Published: 2017
Journal Articles

In Vivo Effects of Lenalidomide on T Cell Proliferation and Immune Checkpoint Molecules in Patients with Advanced Stage CLL: Results from a Phase II Study

Maria Winqvist, MD, Fariba Mozaffari, PhD, Marzia Palma, MD PhD, Sandra Eketorp Sylvan, MD PhD, Hakan Mellstedt, MD PhD, Anders Osterborg, MD PhD, Jeanette Lundin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4164.
https://doi.org/10.1182/blood.V126.23.4164.4164
Published: 2015
Journal Articles

Outcome of Second Line Treatment in Patients with Chronic Lymphocytic Leukemia Did Not Improve 2002-2013: A Population-Based Study from a Well-Defined Geographic Region

Anna Asklid, MD, Agnes Mattsson, MD, Einar Björgvinsson, MD, Maria Winqvist, MD, Sandra Eketorp Sylvan, MD PhD, Frans Søltoft, MSc, Johanna Repits, PhD, Joris Diels, Anders Österborg, MD PhD, Lotta Hansson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4166.
https://doi.org/10.1182/blood.V126.23.4166.4166
Published: 2015